Français | English

José Entenza: complete list of publications

Publications


2013 |  2012 |  2011 |  2010 |  2009 |  2008 |  2007 |  2006 |  2005 |  2004 |  2003 |  2002 |  2001 |  2000 |  1999 |  1998 |  1997 |  1996 |  1995 |  1994 |  1993 |  1992 |  1991 |  1990 | 
 

2013
Veloso T.R., Chaouch A., Roger T., Giddey M., Vouillamoz J., Majcherczyk P., Que Y.A., Rousson V., Moreillon P., Entenza J.M., 2013. Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infection and Immunity 81(3) pp. 697-703. [DOI] [Web of Science] [Pubmed]
2012
Miró J.M., Entenza J.M., Del Río A., Velasco M., Castañeda X., Garcia de la Mària C., Giddey M., Armero Y., Pericàs J.M., Cervera C., Mestres C.A., Almela M., Falces C., Marco F., Moreillon P., Moreno A., Hospital Clinic Experimental Endocarditis Study Group, 2012. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 56(8) pp. 4511-4515. [DOI] [Web of Science] [Pubmed]
Rosin C., Bernsmeier C., Entenza J.M., Moreillon P., Frei R., Weisser M., Flückiger U., 2012. Daptomycin for highly resistant Enterococcus faecium infection. Swiss Medical Weekly 142 pp. w13603. [DOI] [Web of Science] [Pubmed]
2011
Danne C., Entenza J.M., Mallet A., Briandet R., Débarbouillé M., Nato F., Glaser P., Jouvion G., Moreillon P., Trieu-Cuot P., Dramsi S., 2011. Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. Journal of Infectious Diseases 204(12) pp. 1960-1970. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Majcherczyk P., Moreillon P., 2011. In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 55(9) pp. 3977-3984. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Moreillon P., 2011. Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 55(1) pp. 385-387. [DOI] [Web of Science] [Pubmed]
Pea F., Cojutti P., Petrosillo N., Furlanut M., Entenza J.M., Veloso T.R., Vouillamoz J., Giddey M., Moreillon P., 2011. Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 55(9) pp. 4496; author reply 4496-4496; author reply 4497. [DOI] [Pubmed]
Veloso T.R., Amiguet M., Rousson V., Giddey M., Vouillamoz J., Moreillon P., Entenza J.M., 2011. Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans. Infection and Immunity 79(5) pp. 2006-2011. [DOI] [Web of Science] [Pubmed]
2010
Bizzini A., Entenza J.M., Michielin O., Arnold I., Erni B., Moreillon P., 2010. A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii. Antimicrobial Agents and Chemotherapy 54(1) pp. 259-266. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Giddey M., Vouillamoz J., Moreillon P., 2010. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. International Journal of Antimicrobial Agents 35(5) pp. 451-456. [DOI] [Web of Science] [Pubmed]
Nahimana Tessemo I., Bellini C., Entenza J., Zanetti G., Blanc D., 2010. Methicillin-resistant Staphylococcus aureus with intermediate susceptibility to vancomycin: are strict additional contact measures sufficient? pp. S294 in 20th European Congress of Clinical Microbiology and Infectious (ECCMID). Clinical Microgiology and Infection 16(Suppl. 2).
Roger Thierry, Casson Nicola, Croxatto Antony, Entenza Jose Manuel, Pusztaszeri Marc, Akira Shizuo, Reymond Marlies Knaup, Le Roy Didier, Calandra Thierry, Greub Gilbert, 2010. Role of MyD88 and Toll-like receptors 2 and 4 in the sensing of Parachlamydia acanthamoebae. Infection and Immunity 78(12) pp. 5195-5201. [DOI] [Web of Science] [Pubmed]
Ythier M., Entenza J.M., Bille J., Vandenesch F., Bes M., Moreillon P., Sakwinska O., 2010. Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus. Infection and Immunity 78(4) pp. 1711-1716. [DOI] [Web of Science] [Pubmed]
2009
Borel N., Casson N., Entenza J.M., Kaiser C., Pospischil A., Greub G., 2009. Tissue microarray and immunohistochemistry as tools for evaluation of antibodies against Chlamydia-like bacteria. Journal of Medical Microbiology 58(Pt 7) pp. 863-866. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Haldimann A., Giddey M., Lociuro S., Hawser S., Moreillon P., 2009. Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model. Antimicrobial Agents and Chemotherapy 53(9) pp. 3635-3641. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Moreillon P., 2009. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. International Journal of Antimicrobial Agents 34(1) pp. 8.e1-8.e9. [DOI] [Web of Science] [Pubmed]
Hübscher J., McCallum N., Sifri C.D., Majcherczyk P.A., Entenza J.M., Heusser R., Berger-Bächi B., Stutzmann Meier P., 2009. MsrR contributes to cell surface characteristics and virulence in Staphylococcus aureus. FEMS Microbiology Letters 295(2) pp. 251-260. [DOI] [Web of Science] [Pubmed]
2008
Casson N., Entenza J.M., Borel N., Pospischil A., Greub G., 2008. Murine model of pneumonia caused by Parachlamydia acanthamoebae. Microbial Pathogenesis 45(2) pp. 92-97. [DOI] [Web of Science] [Pubmed]
Majcherczyk P.A., Barblan J.L., Moreillon P., Entenza J.M., 2008. Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis. Microbial pathogenesis 45(5-6) pp. 408-414. [DOI] [Web of Science] [Pubmed]
Piroth L., Que Y.A., Widmer E., Panchaud A., Piu S., Entenza J.M., Moreillon P., 2008. The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infection and Immunity 76(8) pp. 3824-3831. [DOI] [Web of Science] [Pubmed]
Vankerckhoven V., Huys G., Vancanneyt M., Vael C., Klare I., Romond M.B., Entenza J.M., Moreillon P., Wind R.D., Knol J., Wiertz E., Pot B., Vaughan E.E., Kahlmeter G., Goossens H., 2008. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends in Food Science and Technology 19(2) pp. 102-114. [DOI] [Web of Science]
Vouillamoz J., Moreillon P., Giddey M., Entenza J.M., 2008. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens. Journal of Antimicrobial Chemotherapy 61(2) pp. 371-374. [DOI] [Web of Science] [Pubmed]
2007
Bizzini A., Entenza J.M., Moreillon P., 2007. Loss of penicillin tolerance by inactivating the carbon catabolite repression determinant CcpA in Streptococcus gordonii. Journal of Antimicrobial Chemotherapy 59(4) pp. 607-615. [DOI] [Web of Science] [Pubmed]
Bizzini A., Majcherczyk P., Beggah-Möller S., Soldo B., Entenza J.M., Gaillard M., Moreillon P., Lazarevic V., 2007. Effects of alpha-phosphoglucomutase deficiency on cell wall properties and fitness in Streptococcus gordonii. Microbiology 153(Pt 2) pp. 490-498. [DOI] [Web of Science] [Pubmed]
Casson N., Entenza J.M., Greub G., 2007. Serological cross-reactivity between different Chlamydia-like organisms. Journal of Clinical Microbiology 45(1) pp. 234-236. [DOI] [Web of Science] [Pubmed]
Moreillon P., Wilson W.R., Leclercq R., Entenza J.M., 2007. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 51(5) pp. 1661-1665. [DOI] [Web of Science] [Pubmed]
Vankerckhoven V., Moreillon P., Piu S., Giddey M., Huys G., Vancanneyt M., Goossens H., Entenza J.M., 2007. Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. Journal of Medical Microbiology 56(8) pp. 1017-1024. [DOI] [Web of Science] [Pubmed]
2006
Bizzini A., Beggah-Möller S., Moreillon P., Entenza J.M., 2006. Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditis. FEMS Immunology and Medical Microbiology 48(3) pp. 419-423. [DOI] [Web of Science] [Pubmed]
Saudan C., Entenza J.M., Baume N., Mangin P., Saugy M., 2006. Short-term stability of testosterone and epitestosterone conjugates in urine samples: quantification by liquid chromatography-linear ion trap mass spectrometry. Journal of Chromatography. B, Analytical Technologies In the Biomedical and Life Sciences 844(1) pp. 168-174. [DOI] [Web of Science] [Pubmed]
Senn L., Entenza J.M., Greub G., Jaton K., Wenger A., Bille J., Calandra T., Prod'hom G., 2006. Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species. BMC Infectious Diseases 6 p. 9. [Document] [DOI] [Web of Science] [Pubmed]
Senn L., Entenza J.M., Prod'hom G., 2006. Adherence of Abiotrophia defectiva and Granulicatella species to fibronectin: is there a link with endovascular infections? FEMS Immunology and Medical Microbiology 48(2) pp. 215-217. [DOI] [Web of Science] [Pubmed]
Vouillamoz J., Moreillon P., Giddey M., Entenza J.M., 2006. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. Journal of Antimicrobial Chemotherapy 58(6) pp. 1208-1214. [DOI] [Web of Science] [Pubmed]
Widmer E., Que Y.A., Entenza J.M., Moreillon P., 2006. New concepts in the pathophysiology of infective endocarditis. Current Infectious Disease Reports 8(4) pp. 271-279. [DOI] [Pubmed]
2005
Entenza J.M., Loeffler J.M., Grandgirard D., Fischetti V.A., Moreillon P., 2005. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrobial Agents and Chemotherapy 49(11) pp. 4789-4792. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Moreillon P., Senn M.M., Kormanec J., Dunman P.M., Berger-Bächi B., Projan S., Bischoff M., 2005. Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infection and Immunity 73(2) pp. 990-998. [DOI] [Web of Science] [Pubmed]
Guignard B., Entenza J.M., Moreillon P., 2005. Beta-lactams against methicillin-resistant Staphylococcus aureus. Current Opinion in Pharmacology 5(5) pp. 479-489. [DOI] [Web of Science] [Pubmed]
Que Y.A., Haefliger J.A., Piroth L., François P., Widmer E., Entenza J.M., Sinha B., Herrmann M., Francioli P., Vaudaux P., Moreillon P., 2005. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. Journal of Experimental Medicine 201(10) pp. 1627-1635. [DOI] [Web of Science] [Pubmed]
Rigoulay C., Entenza J.M., Halpern D., Widmer E., Moreillon P., Poquet I., Gruss A., 2005. Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains. Infection and Immunity 73(1) pp. 563-572. [DOI] [Web of Science] [Pubmed]
2004
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 2004. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Antimicrobial Agents and Chemotherapy 48(1) pp. 86-92. [DOI] [Web of Science] [Pubmed]
Flatz L., Cottagnoud M., Kühn F., Entenza J., Stucki A., Cottagnoud P., 2004. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. Journal of Antimicrobial Chemotherapy 53(2) pp. 305-310. [DOI] [Web of Science] [Pubmed]
2003
Cottagnoud P., Cottagnoud M., Acosta F., Flatz L., Kühn F., Stucki A., Entenza J., 2003. Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis. European Journal of Clinical Microbiology and Infectious Diseases 22(11) pp. 656-662. [DOI] [Web of Science] [Pubmed]
Kühn F., Cottagnoud M., Acosta F., Flatz L., Entenza J., Cottagnoud P., 2003. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro. Antimicrobial Agents and Chemotherapy 47(8) pp. 2487-2491. [DOI] [Web of Science] [Pubmed]
Marchetti O., Moreillon P., Entenza J.M., Vouillamoz J., Glauser M.P., Bille J., Sanglard D., 2003. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrobial Agents and Chemotherapy 47(5) pp. 1565-1570. [DOI] [Web of Science] [Pubmed]
Sanglard D., Ischer F., Marchetti O., Entenza J., Bille J., 2003. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Molecular Microbiology 48(4) pp. 959-976. [DOI] [Web of Science] [Pubmed]
Suarez M., Entenza J.M., Doerries C., Meyer E., Bourquin L., Sutherland J., Marison I., Moreillon P., Mermod N., 2003. Expression of a plant-derived peptide harboring water-cleaning and antimicrobial activities. Biotechnology and Bioengineering 81(1) pp. 13-20. [DOI] [Web of Science] [Pubmed]
2002
Entenza J.M., Hohl P., Heinze-Krauss I., Glauser M.P., Moreillon P., 2002. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis. Antimicrobial Agents and Chemotherapy 46(1) pp. 171-177. [DOI] [Web of Science] [Pubmed]
Moreillon P, Entenza JM, 2002. Résistance, virulence et fitness de Staphylococcus aureus. pp. 109-126 in Infection à l'hôpital: 2ème Journée Maurice Rapin - Aventis. Pneumocoques, staphylocoques actualités. Laboratoires Aventis.
Moreillon P., Dargère S., Piroth L., Entenza J. M., 2002. Prophylaxie de l'endocardite infectieuse : apport du modèle expérimental. Médecine et Maladies Infectieuses 32(11) pp. 605-612. [DOI] [Web of Science]
2001
Bischoff M., Entenza J. M., Giachino P., 09-2001. Influence of a functional sigB operon on the global regulators sar and agr in Staphylococcus aureus. Journal of Bacteriology 183(17) pp. 5171-9. [DOI] [Web of Science] [Pubmed]
Cottagnoud P., Entenza J.M., Cottagnoud M., Que Y.A., Moreillon P., Taüber M.G., 2001. Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiology 1 p. 9. [Document] [Pubmed]
Moreillon P., Entenza J.M., 2001. Antibiotic resistance: learning from animal feeds and animal experimentation. Clinical Microbiology and Infection 7(Suppl. 5) pp. 13-18. [DOI] [Web of Science] [Pubmed]
Que Y.A., François P., Haefliger J.A., Entenza J.M., Vaudaux P., Moreillon P., 2001. Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infection and Immunity 69(10) pp. 6296-6302. [DOI] [Web of Science] [Pubmed]
Stutzmann Meier P., Entenza J.M., Vaudaux P., Francioli P., Glauser M.P., Moreillon P., 2001. Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infection and Immunity 69(2) pp. 657-664. [DOI] [Pubmed]
2000
Entenza J.M., Foster T.J., Ni Eidhin D., Vaudaux P., Francioli P., Moreillon P., 2000. Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus. Infection and Immunity 68(9) pp. 5443-5446. [DOI] [Web of Science] [Pubmed]
Marchetti O., Entenza J.M., Sanglard D., Bille J., Glauser M.P., Moreillon P., 2000. Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans. Antimicrobial Agents and Chemotherapy 44(11) pp. 2932-2938. [DOI] [Web of Science] [Pubmed]
1999
Blanc D.S., Petignat C., Moreillon P., Entenza J.M., Eisenring M., Kleiber H., Wenger A., Troillet N., Blanc C., Francioli P., 1999. Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence. Clinical Infectious Diseases 29(6) pp. 1512-1518. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Caldelari I., Glauser M.P., Moreillon P., 1999. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. Journal of Antimicrobial Chemotherapy 44(6) pp. 775-786. [DOI] [Web of Science] [Pubmed]
Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1999. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 43(1) pp. 77-84. [Web of Science] [Pubmed]
1998
Entenza J.M., Marchetti O., Glauser M.P., Moreillon P., 1998. Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis. Antimicrobial Agents and Chemotherapy 42(8) pp. 1889-1894. [Web of Science] [Pubmed]
Que Y.A., Entenza J.M., Francioli P., Moreillon P., 1998. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 177(1) pp. 146-154. [DOI] [Web of Science] [Pubmed]
1997
Entenza J.M., Caldelari I., Glauser M.P., Francioli P., Moreillon P., 1997. Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii. Journal of Infectious Diseases 175(1) pp. 70-76. [DOI] [Web of Science] [Pubmed]
1996
Vermot D., Entenza J.M., Vouillamoz J., Glauser M.P., Moreillon P., 1996. Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 40(3) pp. 809-811. [Web of Science] [Pubmed]
1995
Entenza J.M., Drugeon H., Glauser M.P., Moreillon P., 1995. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. Antimicrobial Agents and Chemotherapy 39(7) pp. 1419-1424. [Web of Science] [Pubmed]
L'Hériteau F., Entenza J.M., Lacassin F., Leport C., Glauser M.P., Moreillon P., 1995. RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci. Antimicrobial Agents and Chemotherapy 39(7) pp. 1425-1429. [Web of Science] [Pubmed]
Moreillon P., Entenza J.M., Francioli P., McDevitt D., Foster T.J., François P., Vaudaux P., 1995. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infection and Immunity 63(12) pp. 4738-4743. [Web of Science] [Pubmed]
1994
Entenza J.M., Blatter M., Glauser M.P., Moreillon P., 1994. Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci. Antimicrobial Agents and Chemotherapy 38(12) pp. 2683-2688. [Web of Science] [Pubmed]
Entenza J.M., Fluckiger U., Glauser M.P., Moreillon P., 1994. Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Journal of Infectious Diseases 170(1) pp. 100-109. [DOI] [Web of Science] [Pubmed]
1993
Blatter M., Fluckiger U., Entenza J., Glauser M. P., Francioli P., 09-1993. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 37(9) pp. 1971-6. [Web of Science] [Pubmed]
Carsenti-Etesse H., Durant J., Entenza J., Mondain V., Pradier C., Bernard E., Dellamonica P., 04-1993. Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrobial Agents and Chemotherapy 37(4) pp. 921-3. [Web of Science] [Pubmed]
1992
Carsenti-Etesse H., Durant J., Bernard E., Mondain V., Entenza J., Dellamonica P., 08-1992. Effect of subinhibitory concentrations of cefamandole and cefuroxime on adherence of Staphylococcus aureus and Staphylococcus epidermidis to polystyrene culture plates. European Journal of Clinical Microbiology and Infectious Diseases 11(8) pp. 732-7. [DOI] [Web of Science] [Pubmed]
Carsenti-Etesse H., Entenza J., Durant J., Pradier C., Mondain V., Bernard E., Dellamonica P., 1992. Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. Drugs Under Experimental and Clinical Research 18(10) pp. 415-22. [Web of Science] [Pubmed]
Entenza J. M., Calandra T., Moosmann Y., Malinverni R., Glauser M. P., 06-1992. Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats. Antimicrobial Agents and Chemotherapy 36(6) pp. 1256-62. [Web of Science] [Pubmed]
Etesse-Carsenti H., Masseyeff M. F., Entenza J., Monnot F., Giaume F., Barbarin A., Rosset M. J., Argenson C., Dellamonica P., 01-1992. [Contribution of bacterial detachment by enzymatic or physical methods to the diagnosis of foreign material infections and chronic osteomyelitis]. Pathologie-Biologie 40(1) pp. 40-6. [Web of Science] [Pubmed]
1991
Etesse-Carsenti H., Entenza J., Mondain V., Durant J., Pradier C., Bernard E., Dellamonica P., 05-1991. [Effect of fibronectin on the adhesion of staphylococci and interaction with pefloxacin's anti-adherence properties]. Pathologie-Biologie 39(5) pp. 414-23. [Web of Science] [Pubmed]
1990
Etesse-Carsenti H., Masseyeff M. F., Entenza J., Bernard E., Dellamonica P., 04-1990. [Adherence properties and production of slime by staphylococci: relation to pathogenicity]. Pathologie-Biologie 38(4) pp. 249-54. [Web of Science] [Pubmed]

Recherche:
 dans ce site:
   
   
   
 Rechercher
Annuaires      Site map

Biophore - CH-1015 Lausanne  - Suisse  -  Tél. +41 21 692 56 00  -  Fax  +41 21 692 56 05